CEO of Pfizer to step down

By MG News | October 01, 2018 at 05:45 PM GMT+05:00

0:00

October 1, 2018: Us pharmaceutical giant Pfizer has announced that its operating chief Albert Bourla will be the next Chief Executive Officer from January 1 2019, replacing Ian Read who held the top post at the drugmaker for the last eight years.

Read will take over the role of executive chairman, the company said in a statement.

"It's been an honor to serve as Pfizer's CEO for the past eight years. However, now is the right time for a leadership change, and Albert is the right person to guide Pfizer through the coming era," Ian was quoted as saying.

Under Read's tenure, Pfizer won 30 approvals from the U.S. health regulator as well as weathered patent expiration on a few of its blockbusters, including cholesterol drug, Lipitor.

APP

Related News

Name	Price/Vol	%Chg/NChg
KSE100	125,627.31 258.99M	1.00% 1248.25
ALLSHR	78,584.71 1,142.41M	1.16% 904.89
KSE30	38,153.79 69.25M	0.63% 238.06
KMI30	184,886.50 91.38M	0.01% 13.72
KMIALLSHR	53,763.81 554.57M	0.54% 290.61
BKTi	31,921.68 33.15M	1.78% 557.94
OGTi	27,773.98 9.65M	-0.40% -112.21

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	108,055.00	109,565.00 107,195.00	570.00 0.53%
BRENT CRUDE	66.64	67.20 65.92	-0.16 -0.24%
RICHARDS BAY COAL MONTHLY	97.00	97.00 97.00	1.05 1.09%
ROTTERDAM COAL MONTHLY	107.65	107.65 105.85	1.25 1.17%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	64.97	65.82 64.50	-0.55 -0.84%
SUGAR #11 WORLD	16.19	16.74 16.14	-0.52 -3.11%